Lars Fruergaard Jørgensen, Novo Nordisk CEO (Ludovic Marin/ Pool Photo via AP Images)
Novo Nordisk sues unauthorized semaglutide compounders, tempers expectations for Wegovy's global rollout
Novo Nordisk is striking back against illegal semaglutide compounders, filing an initial five lawsuits and preparing more in the coming days and weeks.
The first …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.